Skip to content
  • LinkedIn

The Business of Biofabrication

  • News
  • Perspectives
  • Learn

Medical Devices

  • Xylyx Bio Secures $1.125 Million to Advance Innovations in Xenogeneic Cross-Circulation Transplant Organs
    April 8, 2025

    Xylyx Bio Secures $1.125 Million to Advance Innovations in Xenogeneic Cross-Circulation Transplant Organs

    R.D. Solorzano
  • LyGenesis Receives Green Light to Advance Organ Regeneration Trial
    April 3, 2025

    LyGenesis Receives Green Light to Advance Organ Regeneration Trial

    R.D. Solorzano
  • How Cellino and Matricelf are Advancing Neural Tissue Engineering
    March 18, 2025

    How Cellino and Matricelf are Advancing Neural Tissue Engineering

    R.D. Solorzano
  • Sernova Biotherapeutics Secures FDA Clearance for Thyroid Cell Pouch IND Application
    March 7, 2025

    Sernova Biotherapeutics Secures FDA Clearance for Thyroid Cell Pouch IND Application

    R.D. Solorzano
  • Nurami Medical Secures $30 Million to Accelerate Meningeal Tissue Repair Innovation
    March 7, 2025

    Nurami Medical Secures $30 Million to Accelerate Meningeal Tissue Repair Innovation

    R.D. Solorzano
  • Xenotransplantation Advances: United Therapuetics and eGensis Companies to Watch
    February 26, 2025

    Xenotransplantation Advances: United Therapuetics and eGensis Companies to Watch

    R.D. Solorzano
  • Tissue Therapeutics: The Curative Potential of Combining Cells & Biomaterials
    February 18, 2025

    Tissue Therapeutics: The Curative Potential of Combining Cells & Biomaterials

    R.D. Solorzano
  • BioSapien Extends Pre-Series A Round to $7 Million
    February 11, 2025

    BioSapien Extends Pre-Series A Round to $7 Million

    R.D. Solorzano
  • EU-Funded micro2MACRO Project Aims to Push Cartilage Tissue Regeneration with Bioprinting
    February 6, 2025

    EU-Funded micro2MACRO Project Aims to Push Cartilage Tissue Regeneration with Bioprinting

    R.D. Solorzano
  • United Therapeutics Breaks New Ground with FDA-Cleared Xenotransplantation Trial
    February 5, 2025

    United Therapeutics Breaks New Ground with FDA-Cleared Xenotransplantation Trial

    R.D. Solorzano
Previous Page
1 2 3 4 5 6
Next Page

Archives

To make sense of, stay update on, and learn about
the business of biofabrication

Subscribe

2024 All Rights Reserved

  • Subscribe Subscribed
    • The Business of Biofabrication
    • Already have a WordPress.com account? Log in now.
    • The Business of Biofabrication
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar